Evidence map›Paper›PMID 19841648›Full record

ReviewNature immunology2009

A coming-of-age story: activation-induced cytidine deaminase turns 10.

Rebecca K Delker, Sebastian D Fugmann, F Nina Papavasiliou

Abstract readReview
In one paragraph

Review in Nature immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed.

  1. Article
  2. Review
  3. Mechanisms that regulate the activities of TET proteins.Cellular and molecular life sciences : CMLS · 2022
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Editing base in mouse model.Protein & cell · 2017
    Article
  10. Review
  11. Review
  12. Blood · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Quantifying evolutionary constraints on B-cell affinity maturation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Article
  17. Article
  18. Article
  19. Mouse knockout models for HIV-1 restriction factors.Cellular and molecular life sciences : CMLS · 2014
    Review
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rebecca K DelkerLaboratory of Lymphocyte Biology, Rockefeller University, New York, New York, USA.
Sebastian D Fugmann
F Nina Papavasiliou

Funding

DNA recombination in LymphocytesZIAAG000387 · NIA · NATIONAL INSTITUTE ON AGING · PI SEN, RANJAN · 2009 to 2013
$3.0M
The Regulation of Somatic HypermutationR01CA098495 · NCI · ROCKEFELLER UNIVERSITY · PI PAPAVASILIOU, F. NINA · 2003 to 2012
$2.5M
Intramural NIH HHSNCI NIH HHS CA098495NCI NIH HHS R01 CA098495NIA NIH HHS F31 AG034805
6 · The paper itself

Abstract

The discovery and characterization of activation-induced cytidine deaminase (AID) 10 years ago provided the basis for a mechanistic understanding of secondary antibody diversification and the subsequent generation and maintenance of cellular memory in B lymphocytes, which signified a major advance in the field of B cell immunology. Here we celebrate and review the triumphs in the mission to understand the mechanisms through which AID influences antibody diversification, as well as the implications of AID function on human physiology. We also take time to point out important ongoing controversies and outstanding questions in the field and highlight key experiments and techniques that hold the potential to elucidate the remaining mysteries surrounding this vital protein.

Indexed as

Antibody DiversityProtein Processing, Post-TranslationalRNA Processing, Post-TranscriptionalAICDA (Activation-Induced Cytidine Deaminase)B-LymphocytesCell NucleusCytidine DeaminaseGene Expression RegulationTranscription, GeneticAICDA (Activation-Induced Cytidine Deaminase)Cytidine Deaminase

Identifiers

PMID19841648
PMCPMC2810190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.